Novartis AG (NYSE:NVS)
$ 105.77 0.9 (0.86%) Market Cap: 211.30 Bil Enterprise Value: 229.44 Bil PE Ratio: 12.56 PB Ratio: 5.08 GF Score: 82/100

Novartis AG to Discuss the Oncology Pipeline Update Call Transcript

Jun 15, 2020 / 01:00PM GMT
Release Date Price: $80.58 (+0.96%)
Operator

Good morning and good afternoon, and welcome to the Novartis Oncology Pipeline Update Investor Call. (Operator Instructions) The conference is being recorded (Operator Instructions)

With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir.

Samir Shah
Novartis AG - Global Head of IR

Thank you very much, and a big thank you to all of you who are listening today, a pretty busy time for you all. So good morning and good afternoon.

Before we start and before I hand across to Susanne, I just wanted to go through the safe harbor statement. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's Form 20-F and its most recent quarterly results on Form 6-K that respectively were filed with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot